Missense mutations in CRX homeodomain cause dominant retinopathies through two distinct mechanisms is a research paper published in eLife (2023). On theSindex it has a DataRank of 0.786. It has been cited 22 times, with 13 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0.316
From 12 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 13 citers.
National Institute of Health
Grant: EY012543
National Institute of Health
Grant: EY032136
Research to Prevent Blindness
Grant: Stein Innovation Award
Widłak Family
Grant: CRX Research Fund
NEI NIH HHS
Grant: R01 EY012543
NEI NIH HHS
Grant: R01 EY032136
NEI NIH HHS
Grant: P30 EY002687
National Institutes of Health
Grant: 5R01EY032136-04
Understanding and treating CRX-linked retinopathies
National Institutes of Health
Grant: 5R01EY012543-10
CRX AND ITS REGULATORY NETWORK IN RETINAL DEGENERATIONS
FWCI
2.05
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals